Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bidar

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Annals of Intensive Care|April 1, 2022
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.
Critical Care (London, England)|February 5, 2024
Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients: a prospective multicenter observational studyMatthieu Petit, Frank Bidar, Quentin Fosse, et al.
Ebiomedicine|March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19Fabienne Venet, Morgane Gossez, Frank Bidar, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Annals of Intensive Care|April 1, 2022
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.
Critical Care (London, England)|February 5, 2024
Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients: a prospective multicenter observational studyMatthieu Petit, Frank Bidar, Quentin Fosse, et al.
Ebiomedicine|March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19Fabienne Venet, Morgane Gossez, Frank Bidar, et al.
Pageof 4